Protocol Summaries: GSK1362885
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 111497 | Phase 1 | A single-blind, randomized, placebo controlled, ascending single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1362885 in healthy normal subjects. | Completed |
| 111823 | Phase 1 | A Randomized, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Subjects with Type 2 Diabetes Mellitus | Completed |